quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

We still don’t know how people are really using AI

View original at technologyreview.com
MIT Technology Review - Ai Research Title: We still don’t know how people are really using AI Date: 2026-08-18 10:06 Source: https://www.technologyreview.com/2026/08/18/1142226/how-people-use-ai/ <div></div> <p>AI companies like Anthropic and OpenAI regularly publish reports on how people are using products like Claude…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Anthropic's published research reflects its research teams' specific questions and interests, and it's important to support external independent research.

    60% confidence
  • Having the AI Observatory's bird's-eye-view analysis rather than leaving that information sectioned off into a separate report helps researchers understand the different uses more consistently.

    60% confidence
  • Researchers cannot determine whether Anthropic's general-purpose AI system is used mostly for good or mostly for bad because that information is proprietary.

    60% confidence
  • Anyone making decisions based on AI usage data risks completely operating in the wild and making consequential decisions without knowing what's actually happening beyond company narratives.

    60% confidence
  • Highly consequential decisions about AI's benefits and risks are currently being made on the basis of very limited data.

    60% confidence
  • There is no independent source to corroborate the usage data AI companies publish.

    60% confidence
  • No single company report tells the whole story of AI usage.

    60% confidence

Data points we hold from this source

OpenAI · conversations analyzed1500000 count
OpenAI · work related use share30 percent
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
We still don’t know how people are really using AI — Source | Via News | pt.VIA.NEWS